The advanced imaging analysis solution
SOPHiA for Radiomics is a groundbreaking application that analyzes medical images for research purposes and is an addition to the SOPHiA Platform that has biological and clinical data to offer novel multimodal analyses. This powerful radiomic solution meets the criteria established by the international Image Biomarker Standardization Initiative (IBSI) to deliver finer biomarkers and support researchers.
- Quick AI-powered 3D segmentation
- Centralized Oncoboard for disease monitoring
- Novel multimodal predictive models for research purposes
Centralizes
imaging data (CT-scans, MRI, or PET-CT), biological data (genomics, pathology), and clinical data
Processes
the data using sophisticated statistical models powered by SOPHiA
Delivers
novel multimodal predictions, better treatment evaluation and effective biomarkers to support research efforts
Main Features
SOPHiA Radiomics leverages three main components allowing researchers to gain a deeper understanding of the peculiarities of a given tumor and extract case-specific information for a more precise monitoring.
Accurate measurements of lesions including volume, heterogeneity, and other imaging biomarkers following IBSI-recommended guidelines.
Smart Dashboard for precise evolution prediction and disease monitoring for research purposes.
Advanced statistical analyses for a novel multimodal approach to research.
Applications
SOPHiA Radiomics can already be applied to:
| Meningiomas | ||
| Gliomas (high- & low-grade), including GBMs | ||
| Brain metastases | ||
| Primary lung tumors | ||
| Lung nodules & metastases | ||
| Kidney cancer | * | |
| Adrenal tumors | * | |
| Hepatic metastases | * |
*Soon available
Benefits
Automated and accurate segmentation
Standardized bio-imaging features extraction and monitoring
Novel multimodal predictive features